We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
AUM
$302M
AUM Growth
-$62.9M
Cap. Flow
-$78M
Cap. Flow %
-25.84%
Top 10 Hldgs %
21.72%
Holding
1,314
New
44
Increased
207
Reduced
571
Closed
197

Top Buys

Rank Stock Value
1
DE icon
Deere & Co
DE
+$481K
2
PYPL icon
PayPal
PYPL
+$408K
3
MCD icon
McDonald's
MCD
+$384K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$382K
5
SINA
Sina Corp
SINA
+$323K

Sector Composition

Rank Sector Weight
1 Technology 20.31%
2 Healthcare 12.61%
3 Financials 12.48%
4 Consumer Discretionary 8.71%
5 Energy 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLR icon
301
Fluor
FLR
$7.22B
$140K 0.05%
3,318
-3,800
-53% -$158K
PM icon
302
Philip Morris
PM
$305B
$139K 0.05%
1,250
-627
-33% -$73K
BAX icon
303
Baxter International
BAX
$12.1B
$137K 0.05%
2,190
+1,000
+84% +$61.8K
AKAM icon
304
Akamai
AKAM
$16.4B
$136K 0.05%
2,800
ADNT icon
305
Adient
ADNT
$1.62B
$136K 0.05%
1,620
URI icon
306
United Rentals
URI
$70.2B
$136K 0.05%
980
-1,784
-65% -$213K
EFOR
307
Everforth Inc
EFOR
$884M
$134K 0.04%
2,490
-1,100
-31% -$55K
VUG icon
308
Vanguard Growth ETF
VUG
$216B
$133K 0.04%
6,036
-22,134
-79% -$481K
KEYS icon
309
Keysight
KEYS
$53.6B
$132K 0.04%
3,176
+1
+0% +$41
CLVS
310
DELISTED
Clovis Oncology, Inc.
CLVS
$132K 0.04%
1,600
+600
+60% +$47.6K
DORM icon
311
Dorman Products
DORM
$4.08B
$132K 0.04%
1,840
+1,740
+1,740% +$125K
KRE icon
312
State Street SPDR S&P Regional Banking ETF
KRE
$4.47B
$131K 0.04%
2,312
-310
-12% -$16.7K
WSO icon
313
Watsco Inc
WSO
$15B
$129K 0.04%
800
MDT icon
314
Medtronic
MDT
$108B
$129K 0.04%
1,656
-1,852
-53% -$154K
VGI
315
Virtus Global Multi-Sector Income Fund
VGI
$81.5M
$128K 0.04%
7,076
-1,024
-13% -$17.7K
EFA icon
316
iShares MSCI EAFE ETF
EFA
$76.8B
$128K 0.04%
1,868
-3,457
-65% -$231K
CWB icon
317
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.57B
$128K 0.04%
2,500
-4,499
-64% -$228K
GIS icon
318
General Mills
GIS
$19.5B
$127K 0.04%
2,462
+1
+0% +$55
CCI icon
319
Crown Castle
CCI
$32.4B
$127K 0.04%
1,276
+226
+22% +$23.1K
SYNA icon
320
Synaptics
SYNA
$4.55B
$127K 0.04%
3,236
-149
-4% -$6.72K
FBT icon
321
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.8B
$126K 0.04%
1,020
+36
+4% +$4.26K
EXG icon
322
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.92B
$126K 0.04%
+13,500
New +$125K
RMP
323
DELISTED
Rice Midstream Partners LP
RMP
$125K 0.04%
5,950
-1,200
-17% -$24.6K
ATHN
324
DELISTED
Athenahealth, Inc.
ATHN
$124K 0.04%
1,000
FXH icon
325
First Trust Health Care AlphaDEX Fund
FXH
$1.02B
$124K 0.04%
1,836
-1,632
-47% -$109K

Similar funds

Winslow Evans & Crocker's Q3 2017 Portfolio in Review

As of Q3 2017, Winslow Evans & Crocker held 1,314 positions worth $302M, down 17% from $365M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Winslow Evans & Crocker withdrew a net $78M in Q3 2017, closing 197 positions and reducing 571 holdings. Its most notable exit was Veeva Systems, an estimated $619K position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Winslow Evans & Crocker opened a new position in Regeneron Pharmaceuticals worth $358K.

  • Winslow Evans & Crocker's largest Q3 2017 buy was Regeneron Pharmaceuticals: 802 shares worth $358K.
  • Winslow Evans & Crocker added most to Deere & Co in Q3 2017, an estimated $481K increase.
  • Winslow Evans & Crocker's biggest Q3 2017 reduction was Microsoft, cutting an estimated $2.03M.
  • Winslow Evans & Crocker fully exited Veeva Systems in Q3 2017, selling an estimated $619K.
  • Winslow Evans & Crocker's ten largest holdings make up 22% of its $302M portfolio in Q3 2017.
  • Winslow Evans & Crocker opened 44 new positions and closed 197 in Q3 2017.
  • Winslow Evans & Crocker's portfolio value fell 17% quarter-over-quarter to $302M.

Based on Winslow Evans & Crocker's 13F filing for Q3 2017, filed 19 Oct 2017.